Showing results (421-430 of 504) with videos related to

Sort By:
Pageof 51
Canadian Medical Association Journal|November 8, 1975
Arterial hypertension and neurofibromatosis: renal artery stenosis and coarctation of abdominal aortaW Schürch, F H Messerli, J Genest, et al.
Endocrinology|June 1, 1986
Fate of [125I]angiotensin II in adrenal zona glomerulosa cellsC Bianchi, J Gutkowska, A De Léan, et al.
Current Eye Research|April 1, 1986
Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eyeC Bianchi, M B Anand-Srivastava, A De Léan, et al.
The Canadian Journal of Cardiology|May 14, 1999
Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research GroupP W Connelly, M Poapst, J Davignon, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
Primary hyperaldosteronism: a pituitary--adrenal dysfunction related to a new pituitary glycopeptide?M Chrétien, M Lis, N Larivière, et al.
Contributions to Nephrology|January 1, 1977
Catecholamines, cyclic AMP and renin in two contrasting forms of essential hypertensionO Kuchel, N T Buu, P Hamet, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1986
Identification of the released form of atrial natriuretic factor by the perfused rat heartG Thibault, R Garcia, J Gutkowska, et al.
The American Journal of Clinical Nutrition|September 22, 2001
Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjectsL Mabile, A Piolot, L Boulet, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1986
Some physiopathological aspects of atrial natriuretic factorR Garcia, M Cantin, J R Cusson, et al.
Circulation Research|June 1, 1976
Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertensionF H Messerli, O Kuchel, P Hamet, et al.
Pageof 51